Product Concentration: 0.5 mg/ml
FormulationThis Biotinylated antibody is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Storage condition :
This biotinylated antibody is stable when stored at 2-8°C. Do not freeze.
This Biotinylated antibody is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
State of Matter
Liquid
Storage and Handling
This biotinylated antibody is stable when stored at 2-8°C. Do not freeze.
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.
Description
Specificity
VL-4 activity is directed against LCMV nucleoprotein, staining LCMV-infected cells internally.
VL-4 does not react with influenza-, vaccinia-, or vesicular stomatitis-infected cells.
Background
Lymphocytic choriomeningitis virus (LCMV) is a neglected human pathogenic arenavirus with worldwide distribution. Arenaviruses cause human infection through mucosal exposure to aerosols or by direct contact with abraded skin of infected rodents . LCMV infection may carry health risks for humans who are immunocompromised or pregnant .
.png "ACE2/HEK293 Stable Cell Line")
